Cystatin C and contrast-induced nephropathy

Nephrology Dialysis Transplantation

Volumn 23, Issue 12, 2008, Pages 4079-

  Gambaro, Giovanni ^a   Graziani, Maria Stella ^b   Ribichini, Flavio ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CONTRAST MEDIUM; CYSTATIN C;

CONTRAST MEDIUM INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; LETTER; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CONTRAST MEDIA; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; RENAL INSUFFICIENCY;

EID: 56749177332     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn507     Document Type: Letter

References (3)

1. Kimmel M, Butscheid M, Brenner S et al. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc - preliminary results. Nephrol Dial Transplant 2008; 23: 1241-1245
2. Niccoli G, Conte M, Della Bona R et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate. Atherosclerosis 2008; 198: 373-380
3. Keevil BG, Kilpatrick ES, Nichols SP et al. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-1539